Improving Treatment Outcomes For Children With Autism: Translating Intensive 1:1 Treatment Into A Group-Based Community Model
Funder
National Health and Medical Research Council
Funding Amount
$318,669.00
Summary
Current best-practice treatment guidelines for children with Autism state that each child should receive a minimum of 20 hours of Early Intensive Behavioural Intervention per week. However, this is not possible due to the enormous cost and time pressure involved and the lack of trained specialists in Australia and overseas. To address this problem, I will examine the effectiveness of translating an evidence-based individualised treatment program into a lower-cost, but equally effective, group-ba ....Current best-practice treatment guidelines for children with Autism state that each child should receive a minimum of 20 hours of Early Intensive Behavioural Intervention per week. However, this is not possible due to the enormous cost and time pressure involved and the lack of trained specialists in Australia and overseas. To address this problem, I will examine the effectiveness of translating an evidence-based individualised treatment program into a lower-cost, but equally effective, group-based community model.Read moreRead less
Improving Outcomes For Children With Common Developmental Conditions: Identifying Risk And Protective Factors And Developing Targeted Interventions
Funder
National Health and Medical Research Council
Funding Amount
$307,946.00
Summary
Attention Deficit Hyperactivity Disorder (ADHD) and language impairment (LI) are both highly prevalent and associated with mental health difficulties. This research will investigate 1) risk factors for poor versus better mental health, academic and social outcomes in children with ADHD and LI and 2) the development and piloting of interventions targeting these factors. This research will indicate avenues for new methods of intervention and prevention for children with ADHD and LI.
Defining The Role Of Genetic Variants In Systemic Lupus Erythematosus: Copy Number Variants And Epigenetic Mechanisms
Funder
National Health and Medical Research Council
Funding Amount
$338,625.00
Summary
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease associated with increased risk of mortality, severely impacting the quality of life for those affected. A large number of genes have been implicated in SLE susceptibility, however we know little of the genetic mechanisms proceeding disease onset. This project uses state of the art technology to define the role of genetic variants in SLE susceptibility and identify their importance across patients of different ethnic backgrounds.
The government is committed to reducing the gap in Aboriginal health. This research is part of the Study of Environment on Aboriginal Resilience and Child Health; Australia’s largest prospective, longitudinal study of urban Aboriginal children. It will provide, for the first time, comprehensive information about the causes of health and illness in a large group of urban Aboriginal children. It will identify factors that can be changed in families and early childhood to prevent later disease.
Evaluating Recently Introduced Prevention Strategies And Investigating Further Aetiologies Of Cerebral Palsy
Funder
National Health and Medical Research Council
Funding Amount
$314,644.00
Summary
Cerebral palsy is an early brain injury that affects movement. Every year in Australia, this life long condition will be identified in another 600 infants. This Early Career Fellowship will train an Australian researcher to evaluate promising prevention strategies that could reduce the overall incidence of cerebral palsy for the first time. The researcher will also investigate other causes of cerebral palsy including birth defects that occur very early in pregnancy.
Novel Actions Of HDL Cholesterol: A Potential New Strategy For Treatment Of Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$74,973.00
Summary
There are currently in excess of 170 million patients diagnosed with type 2 diabetes worldwide. Recent studies have identified novel actions of HDL cholesterol in relation to glucose and fat metabolism which provide a rationale for therapeutic approaches to raise levels of circulating HDL to manage the metabolic syndrome and type 2 diabetes. This research will investigate HDL signaling pathways and contribute significantly to our understanding of the metabolic actions of HDL in Humans.